Anebulo Pharmaceuticals Quote - ANEB

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.05

Bid

1.11

Offer

1.25

Volume

113

0.00 Day's Range 0.00

0.8001 52 Week Range 3.30

Market Cap

27.23M

Previous Close

1.25

Open

Last Trade

1.05

Last Trade Time

22:14:40

Financial Volume

VWAP

Average Volume (3m)

19,088

Shares Outstanding

25,933,217

Dividend Yield

PE Ratio

-3.95

Earnings Per Share (EPS)

-0.32

Revenue

Net Profit

-8.2M

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.anebulo.com

Headquarters

Dover, Delaware, USA

Founded

Anebulo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANEB. The last closing price for Anebulo Pharmaceuticals was US$1.25. Over the last year, Anebulo Pharmaceuticals shares have traded in a share price range of US$ 0.8001 to US$ 3.30.

Anebulo Pharmaceuticals currently has 25,933,217 shares in issue. The market capitalisation of Anebulo Pharmaceuticals is US$32.42 million. Anebulo Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.95.

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.2	-16	1.25	1.3899	0.8001	156484	1.19769947	CS
4	-0.36	-25.5319148936	1.41	1.62	0.8001	47878	1.22710847	CS
12	-0.88	-45.5958549223	1.93	2.1	0.8001	19088	1.32664748	CS
26	-1.69	-61.6788321168	2.74	3.08	0.8001	13274	1.66233173	CS
52	-1.44	-57.8313253012	2.49	3.3	0.8001	10175	1.96546902	CS
156	-5.35	-83.59375	6.4	7.885	0.8001	9502	2.90949197	CS
260	-6.33	-85.7723577236	7.38	9.33	0.8001	10662	4.05232256	CS

ANEB - Frequently Asked Questions (FAQ)

What is the current Anebulo Pharmaceuticals share price?

The current share price of Anebulo Pharmaceuticals is US$ 1.05

How many Anebulo Pharmaceuticals shares are in issue?

Anebulo Pharmaceuticals has 25,933,217 shares in issue

What is the market cap of Anebulo Pharmaceuticals?

The market capitalisation of Anebulo Pharmaceuticals is USD 32.42M

What is the 1 year trading range for Anebulo Pharmaceuticals share price?

Anebulo Pharmaceuticals has traded in the range of US$ 0.8001 to US$ 3.30 during the past year

What is the PE ratio of Anebulo Pharmaceuticals?

The price to earnings ratio of Anebulo Pharmaceuticals is -3.95

What is the reporting currency for Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals reports financial results in USD

What is the latest annual profit for Anebulo Pharmaceuticals?

The latest annual profit of Anebulo Pharmaceuticals is USD -8.2M

What is the registered address of Anebulo Pharmaceuticals?

The registered address for Anebulo Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, KENT, DOVER, DELAWARE, 19904

What is the Anebulo Pharmaceuticals website address?

The website address for Anebulo Pharmaceuticals is www.anebulo.com

Which industry sector does Anebulo Pharmaceuticals operate in?

Anebulo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AVGRAvinger Inc	US$ 2.00 (211.33%)	45.32M
BAOSBaosheng Media Group Holdings Ltd	US$ 3.66 (111.56%)	11.22M
CMNDClearmind Medicine Inc	US$ 2.42 (98.36%)	16.2M
TIVCTivic Health Systems Inc	US$ 0.403 (79.59%)	38.75M
ATNF180 Life Sciences Corporation	US$ 3.29 (75.94%)	8.81M
SLGLSol Gel Technologies Ltd	US$ 0.9999 (-39.40%)	539.97k
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF	US$ 14.95 (-32.72%)	1.57k
GLDDGreat Lakes Dredge and Dock Corporation	US$ 9.01 (-21.96%)	2
KALVKalVista Pharmaceuticals Inc	US$ 7.00 (-20.72%)	168
LGHLWLion Group Holding Ltd	US$ 0.006 (-20.00%)	10.02k
SVMHSRIVARU Holding Ltd	US$ 0.032 (14.29%)	138.16M
AVGRAvinger Inc	US$ 2.00 (211.33%)	45.32M
TIVCTivic Health Systems Inc	US$ 0.403 (79.59%)	38.75M
CMNDClearmind Medicine Inc	US$ 2.42 (98.36%)	16.2M
LAESSEALSQ Corporation	US$ 6.25 (27.55%)	16.12M